Merck Shares Outstanding 2006-2020 | MKGAF

Merck shares outstanding history from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Merck shares outstanding for the quarter ending March 31, 2020 were 0.434B, a 1.16% decline year-over-year.
  • Merck 2019 shares outstanding were 0.435B, a 0% decline from 2018.
  • Merck 2018 shares outstanding were 0.435B, a 0% decline from 2017.
  • Merck 2017 shares outstanding were 0.435B, a 0% decline from 2016.
Merck Annual Shares Outstanding
(Millions of Shares)
2019 435
2018 435
2017 435
2016 435
2015 435
2014 435
2013 435
2012 435
2011 435
2010 435
2009 435
2008 434
2007 432
2006 388
2005 382
Merck Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 434
2019-12-31 435
2019-09-30 434
2019-06-30 435
2019-03-31 440
2018-12-31 435
2018-09-30 436
2018-06-30 433
2018-03-31 437
2017-12-31 435
2017-09-30 436
2017-06-30 434
2017-03-31 434
2016-12-31 435
2016-09-30 435
2016-06-30 433
2016-03-31 435
2015-12-31 433
2015-09-30 433
2015-06-30 435
2015-03-31 435
2014-12-31 438
2014-09-30 438
2014-06-30 435
2014-03-31 217
2013-12-31 435
2013-09-30 435
2013-06-30 435
2013-03-31 435
2012-12-31 435
2012-09-30 436
2012-06-30 435
2012-03-31 435
2011-12-31 435
2011-09-30 435
2011-06-30 435
2011-03-31 435
2010-12-31 435
2010-09-30 435
2010-06-30 437
2010-03-31 435
2009-12-31 435
2009-09-30 1,331
2009-06-30 434
2009-03-31 436
2008-12-31 434
2008-09-30 435
2008-06-30 437
2008-03-31 435
2007-12-31 432
2007-09-30 426
2007-06-30 438
2007-03-31 415
2006-12-31 388
2006-09-30 380
2006-06-30 382
2006-03-31 381
2005-12-31 382
2005-09-30 382
2005-06-30 382
2005-03-31 380
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.075B $18.092B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.390B 37.11
Takeda Pharmaceutical (TAK) Japan $54.479B 9.55
Astellas Pharma (ALPMY) Japan $29.584B 14.99
Eisai (ESALY) Japan $24.627B 21.35
UCB SA (UCBJF) Belgium $23.856B 0.00
Grifols, S.A (GRFS) Spain $12.802B 15.91
Catalent (CTLT) United States $12.260B 47.40
Neurocrine Biosciences (NBIX) United States $12.217B 56.46
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.421B 44.77
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.936B 31.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.837B 9.34
United Therapeutics (UTHR) United States $5.146B 9.75
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.595B 501.67
Nektar Therapeutics (NKTR) United States $4.348B 0.00
Evotec AG (EVTCY) Germany $4.090B 110.22
Hypermarcas (HYPMY) Brazil $3.793B 13.95
FibroGen (FGEN) United States $3.726B 0.00
PTC Therapeutics (PTCT) United States $3.724B 0.00
ChemoCentryx (CCXI) United States $3.654B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.493B 10.24
Pacira BioSciences (PCRX) United States $2.423B 49.59
Sage Therapeutics (SAGE) United States $2.290B 0.00
Cronos Group (CRON) Canada $2.100B 60.20
Corcept Therapeutics (CORT) United States $1.920B 19.03
Xencor (XNCR) United States $1.821B 0.00
USANA Health Sciences (USNA) United States $1.725B 17.69
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.719B 0.00
Akebia Therapeutics (AKBA) United States $1.628B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.571B 12.02
Indivior (INVVY) United States $1.556B 19.31
Zogenix (ZGNX) United States $1.539B 0.00
Esperion Therapeutics (ESPR) United States $1.428B 0.00
Heron Therapeutics (HRTX) United States $1.419B 0.00
Karyopharm Therapeutics (KPTI) United States $1.378B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.351B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.306B 14.06
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.080B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.022B 45.63
BioCryst Pharmaceuticals (BCRX) United States $0.975B 0.00
Tilray (TLRY) Canada $0.925B 0.00
ImmunoGen (IMGN) United States $0.841B 0.00
Endo (ENDP) Ireland $0.772B 1.20
Radius Health (RDUS) United States $0.616B 0.00
VAXART, INC (VXRT) United States $0.608B 0.00
Trillium Therapeutics (TRIL) Canada $0.603B 0.00
Aerie Pharmaceuticals (AERI) United States $0.603B 0.00
Molecular Templates (MTEM) United States $0.596B 0.00
Collegium Pharmaceutical (COLL) United States $0.589B 0.00
Ardelyx (ARDX) United States $0.587B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.558B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.519B 12.55
Crinetics Pharmaceuticals (CRNX) United States $0.512B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.470B 18.35
Flexion Therapeutics (FLXN) United States $0.469B 0.00
Siga Technologies (SIGA) United States $0.462B 0.00
DURECT (DRRX) United States $0.425B 0.00
Harpoon Therapeutics (HARP) United States $0.403B 0.00
TherapeuticsMD (TXMD) United States $0.399B 0.00
Ocular Therapeutix (OCUL) United States $0.398B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.386B 0.00
Calithera Biosciences (CALA) United States $0.368B 0.00
MEI Pharma (MEIP) United States $0.365B 0.00
Organogenesis Holdings (ORGO) United States $0.352B 0.00
Altimmune (ALT) United States $0.314B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.307B 0.00
Concert Pharmaceuticals (CNCE) United States $0.302B 0.00
PROFOUND MEDICL (PROF) Canada $0.287B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.286B 0.00
Taiwan Liposome (TLC) Taiwan $0.256B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.47
Oasmia Pharmaceutical AB (OASMY) Sweden $0.248B 0.00
Redhill Biopharma (RDHL) Israel $0.242B 0.00
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 5.19
KalVista Pharmaceuticals (KALV) United States $0.216B 0.00
Rafael Holdings (RFL) United States $0.196B 0.00
OptiNose (OPTN) United States $0.195B 0.00
IMV INC (IMV) Canada $0.181B 0.00
Nivalis Therapeutics (ALPN) United States $0.176B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 23.08
Aquestive Therapeutics (AQST) United States $0.152B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.140B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.134B 0.00
Otonomy (OTIC) United States $0.119B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.111B 0.00
MediWound (MDWD) Israel $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.102B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.100B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Xeris Pharmaceuticals (XERS) United States $0.097B 0.00
CTI BioPharma (CTIC) United States $0.095B 0.00
Onconova Therapeutics (ONTX) United States $0.094B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
Hemispherx BioPharma (AIM) United States $0.087B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Sundial Growers (SNDL) Canada $0.085B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Heat Biologics (HTBX) United States $0.079B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.067B 0.00
Lipocine (LPCN) United States $0.064B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.09
PolarityTE (PTE) United States $0.048B 0.00
IsoRay (ISR) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 7.56
Opiant Pharmaceuticals (OPNT) United States $0.040B 84.54
Novan (NOVN) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Jaguar Animal Health (JAGX) United States $0.038B 0.00
GTx (ONCT) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
AgeX Therapeutics (AGE) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.14
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00